Dielectrophoretic capture and genetic analysis of single neuroblastoma tumor cells

• Published in: Frontiers in oncology Vol. 4; p. 201
• Main Authors: Carpenter, Erica L, Rader, JulieAnn, Ruden, Jacob, Rappaport, Eric F, Hunter, Kristen N, Hallberg, Paul L, Krytska, Kate, O'Dwyer, Peter J, Mosse, Yael P
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 01.01.2014
• Subjects: circulating tumor cell; disseminated tumor cell; Neuroblastoma; Oncology; single cell capture; targeted sequencing; whole genome amplification; targeted sequencing; neuroblastoma; circulating tumor cell; disseminated tumor cell; single cell capture; whole genome amplification
• ISSN: 2234-943X; 2234-943X
• DOI: 10.3389/fonc.2014.00201

Our understanding of the diversity of cells that escape the primary tumor and seed micrometastases remains rudimentary, and approaches for studying circulating and disseminated tumor cells have been limited by low throughput and sensitivity, reliance on single parameter sorting, and a focus on enumeration rather than phenotypic and genetic characterization. Here, we utilize a highly sensitive microfluidic and dielectrophoretic approach for the isolation and genetic analysis of individual tumor cells. We employed fluorescence labeling to isolate 208 single cells from spiking experiments conducted with 11 cell lines, including 8 neuroblastoma cell lines, and achieved a capture sensitivity of 1 tumor cell per 10(6) white blood cells (WBCs). Sample fixation or freezing had no detectable effect on cell capture. Point mutations were accurately detected in the whole genome amplification product of captured single tumor cells but not in negative control WBCs. We applied this approach to capture 144 single tumor cells from 10 bone marrow samples of patients suffering from neuroblastoma. In this pediatric malignancy, high-risk patients often exhibit wide-spread hematogenous metastasis, but access to primary tumor can be difficult or impossible. Here, we used flow-based sorting to pre-enrich samples with tumor involvement below 0.02%. For all patients for whom a mutation in the Anaplastic Lymphoma Kinase gene had already been detected in their primary tumor, the same mutation was detected in single cells from their marrow. These findings demonstrate a novel, non-invasive, and adaptable method for the capture and genetic analysis of single tumor cells from cancer patients.